15-89750672-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_018670.4(MESP1):c.560G>T(p.Arg187Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000973 in 1,356,610 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018670.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MESP1 | NM_018670.4 | c.560G>T | p.Arg187Leu | missense_variant | 1/2 | ENST00000300057.5 | NP_061140.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MESP1 | ENST00000300057.5 | c.560G>T | p.Arg187Leu | missense_variant | 1/2 | 1 | NM_018670.4 | ENSP00000300057.4 | ||
MESP1 | ENST00000559894.1 | n.114+352G>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000546 AC: 83AN: 152144Hom.: 2 Cov.: 34
GnomAD3 exomes AF: 0.000185 AC: 1AN: 5402Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 3052
GnomAD4 exome AF: 0.0000399 AC: 48AN: 1204358Hom.: 0 Cov.: 66 AF XY: 0.0000292 AC XY: 17AN XY: 582302
GnomAD4 genome AF: 0.000552 AC: 84AN: 152252Hom.: 2 Cov.: 34 AF XY: 0.000564 AC XY: 42AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 06, 2023 | The c.560G>T (p.R187L) alteration is located in exon 1 (coding exon 1) of the MESP1 gene. This alteration results from a G to T substitution at nucleotide position 560, causing the arginine (R) at amino acid position 187 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 11, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with MESP1-related conditions. This variant is present in population databases (rs556672934, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 187 of the MESP1 protein (p.Arg187Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at